Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994-2000

International Journal of Antimicrobial Agents

Volumn 19, Issue 6, 2002, Pages 557-564

  Wagenlehner, F M E ^a   Niemetz, A ^b   Dalhoff, A ^c   Naber, K G ^a  

^a Urologische Klinik   (Germany)

^b Niemetz GmbH   (Austria)

^c BAYER AG   (Germany)

Author keywords

Antibiotic resistance; Resistance mechanisms; Urinary tract infections

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; MEZLOCILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CELL CULTURE; CONFERENCE PAPER; ENTEROCOCCUS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HOSPITALIZATION; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPECTRUM; STAPHYLOCOCCUS; URINARY TRACT INFECTION; ARTICLE; BACTERIAL INFECTION; GERMANY; HOSPITAL PATIENT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANTIBIOTICS; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; GERMANY; HUMAN; INPATIENTS; MICROBIAL SENSITIVITY TESTS; URINARY TRACT INFECTIONS; ANTI-BACTERIAL AGENTS; HUMANS;

EID: 0036021496     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00100-0     Document Type: Conference Paper

References (27)

1. Prevalence of nosocomial infections in representative German hospitals
2. Mechanisms of fluoroquinolone resistance: An update 1994-1998
3. Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus
4. In vitro activities of six quinolones and mechanisms of resistance in Staphylococcus aureus and coagulase-negative staphylococci
5. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii
6. Molecular mechanisms of resistance to trimethoprim
7. Mechnaisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole
8. A glutamine 67→ histidine mutation in homotetrameric R67 dihydrofolate reductase results in four mutations per single active site pore and causes substantial substrate and cofactor inhibition
9. Antibiotic resistance in staphylococci
10. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci
11. Intrinsic penicillin resistance in enterococci
12. D-Ala-D-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB
13. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Eschericia coli
14. SHV-1 beta-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae
15. Chromosomal beta-lactamase expression and antibiotic resistance in Enterobacter cloacae
16. Antibiotic efflux, a mechanism of multiple resistance in Pseudomonas aeruginosa
17. Und eine Expertengruppe der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. Einteilung der Oralcephalosporine
18. Cefuroxime resistance in Escherichia coli. Resistance mechanisms and prevalence
19. Diversity of TEM mutants in Proteus mirabilis
20. Extended-spectrum beta-lactamases
21. Resistance patterns among nosocomial pathogens: Trends over the past few years
22. Aminoglycoside resistance mediated by the bifunctional enzyme 6′-N-aminoglycoside acetyltransferase-2″-O-aminoglycoside phosphotransferase
23. The most frequently occurring aminoglycoside resistance mechanisms-combined results of surveys in eight regions of the world
24. In-vitro-Aktivität von fünf Fluorchinolonen, Gentamicin, Amoxicillin/ Clavulansäure und Cotrimoxazol gegnüber Erregern von komplizierten Harnwegsinfektionen
25. On behalf of the co-operative group of the European study group on Nosocomial infections (ESGNI). A European perspective on nosocomial urinary tract infections I. report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study)
26. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia
27. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy